Adia Nutrition Inc. (OTCQB: ADIA) announced key business updates and financial results, highlighting significant growth and strategic progress in 2025. The company reported a revenue surge exceeding 200% quarter-over-quarter in the third quarter, with profit margins above 20%, attributed to strong demand for Adia Med clinics and Adia Labs regenerative products. Adia Nutrition has tripled its sales force and established four regional divisions to enhance nationwide and international distribution. The company also completed the divestiture of its non-core coffee subsidiary, Biolete Coffee, retaining an 18% equity stake. Additionally, Adia Nutrition is preparing to file its SEC Form 10 registration statement by the end of November 2025, aiming for full effectiveness by late January 2026 as part of its strategy to secure a Nasdaq listing.